The cycle of quality as a model for improving health outcomes in the treatment of hypertension

European Heart Journal, Supplement

Volumn 9, Issue B, 2007, Pages

  Califf, Robert M ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cycle of quality; Hypertension; Outcomes; Quality

Indexed keywords

EID: 61749101752     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sum002     Document Type: Article

References (15)

1. Asch SM, McGlynn EA, Hiatt L, Adams J, DeCristofaro A, Chen R, LaPuerta P, Kerr EA. Quality of care for hypertension in the United States. BMC Cardiovasc Dis 2005;5:1.
2. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-2645.
3. Califf RM, Peterson ED, Gibbons RJ, Garson A Jr, Brindis RG, Beller GA, Smith SC Jr; American College of Cardiology; American Heart Association. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol 2002;40:1895-1901.
4. Kohn LT, Corrigan JM, Donaldson MS, eds.To Err is Human: Building a Better Health System. Washington, DC: Institute of Medicine - National Academy Press; 2000.
5. Califf RM, DeMets DL. Principles from clinical trials relevant to clinical practice: Part I. Circulation 2002;106:1015-1021.
6. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
7. Moses H III, Dorsey ER, Matheson DH, Thier SO. Financial anatomy of biomedical research. JAMA 2005;294:1333-1342.
8. Zerhouni EA. Translational and clinical science - time for a new vision. N Engl J Med 2005;353:1621-1623.
9. Sung NS, Crowley WF Jr, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D. Central challenges facing the national clinical research enterprise. JAMA 2003;289:1278-1287.
10. Califf RM, Harrington RA, Madre LK, Peterson ED, Roth D, Schulman KA. Curbing the cardiovascular disease epidemic: Aligning industry, government, payers, and academics. Health Aff (Millwood) 2007; 26:62-74.
11. Al-Khatib SM, Califf RM, Hasselblad V, Alexander JH, McCrory DC, Sugarman J. Medicine placebo-controls in short-term clinical trials of hypertension. Science 2001;292:2013-2015.
12. Al-Khatib SM. Placebo-controls in short-term clinical trials of hypertension. Presented at Center for Drug Evaluation and Research Cardiovascular and Renal Drugs Advisory Committee meeting, 26 April 2006, Gaithersburg, MD. http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4215S2-02- index.htm.
13. Eichacker PQ, Natanson C, Danner RL. Surviving sepsis-practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 2006;355:1640-1642.
14. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-2098.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, Blood Institute Joint National Committee on Prevention, Detection, Evaluation, Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.